Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.4K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.4K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

214
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
214
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

628
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
628
Regulation of Stroke Volume01:27

Regulation of Stroke Volume

3.4K
The regulation of stroke volume, which is the amount of blood the heart pumps out during each heartbeat, is critical for maintaining a healthy circulatory system. Stroke volume is influenced by three main factors: preload, contractility, and afterload.
Preload refers to the degree of stretch on the heart before it contracts. It's analogous to the stretching of a rubber band; the more it's stretched, the more forcefully it snaps back. This concept is encapsulated in the Frank-Starling law of the...
3.4K
Dementia01:30

Dementia

155
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
155
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

424
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
424

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Cognitive health of Moscow residents 55 years and older: Epidemiological data].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Myoclonus in Alzheimer's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Therapy prospects for post-stroke aphasia].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Results of the program to preserve cognitive skills and psycho-emotional health in Moscow Longevity Centers].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[A new look at blood biomarkers in Alzheimer's patients].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2026
Same author

[Epileptic seizures in patients with Alzheimer's disease].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·2025

Related Experiment Video

Updated: Aug 24, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.1K

[Vascular cognitive impairment].

A N Bogolepova1,2

  • 1Pirogov Russian National Research Medical University, Moscow, Russia.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|October 24, 2022
PubMed
Summary
This summary is machine-generated.

Vascular cognitive impairment, often caused by stroke and small vessel disease, affects multiple cognitive domains. Early diagnosis and treatment, potentially with nicergoline, are crucial for managing this condition.

Keywords:
Sermionnicergolinesmall vessel diseasestrokevascular cognitive impairment

More Related Videos

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

667
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K

Related Experiment Videos

Last Updated: Aug 24, 2025

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

3.1K
A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis
05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

667
Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients
07:42

Dual-Task Stroop Paradigm for Detecting Cognitive Deficits in High-Functioning Stroke Patients

Published on: December 16, 2022

3.1K

Area of Science:

  • Neurology
  • Gerontology
  • Neuroscience

Context:

  • Vascular cognitive impairment (VCI) is the second leading cause of dementia.
  • Stroke significantly elevates dementia risk, with delayed-onset dementia linked to small vessel disease or concurrent Alzheimer's.
  • Cerebral small vessel disease is a primary driver of VCI, independent of stroke, characterized by steady progression.

Purpose:

  • To review the mechanisms, characteristics, and management of vascular cognitive impairment.
  • To highlight the role of cerebral small vessel disease in cognitive decline.
  • To discuss the therapeutic potential of nicergoline in VCI.

Summary:

  • Vascular cognitive impairment encompasses a spectrum of cognitive deficits impacting processing speed, attention, and executive functions.
  • It is characterized by gradual cognitive decline, heterogeneous presentation, and affects all major cognitive domains.
  • Nicergoline demonstrates efficacy in VCI by enhancing cerebral blood flow, cholinergic neurotransmission, and providing neuroprotection.

Impact:

  • Emphasizes the need for early diagnosis and timely intervention in managing VCI.
  • Underscores the significance of addressing small vessel disease for cognitive health.
  • Positions nicergoline as a potential therapeutic agent for improving outcomes in vascular cognitive impairment.